TrialCancer chemotherapy and pharmacology2016

A phase I pharmacokinetics study comparing PF-06439535 (a potential biosimilar) with bevacizumab in healthy male volunteers.

Beverly Knight et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.